Previous Article | Next Article ![]()
Journal of Virology, December 2008, p. 11979-11984, Vol. 82, No. 23
0022-538X/08/$08.00+0 doi:10.1128/JVI.00867-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan,1 Core Facility for Therapeutic Vectors, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai Minato-ku, Tokyo 108-8639, Japan,2 RNA and Biofunctions, PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan3
Received 24 April 2008/ Accepted 2 September 2008
Live attenuated vaccines against measles have been developed through adaptation of clinical isolates of measles virus (MV) in various cultured cells. Analyses using recombinant MVs with chimeric genomes between wild-type and Edmonston vaccine strains indicated that viruses possessing the polymerase protein genes of the Edmonston strain exhibited attenuated viral gene expression and growth in cultured cells as well as in mice expressing an MV receptor, signaling lymphocyte activation molecule, regardless of whether the virus genome had the wild-type or vaccine-type promoter sequence. These data demonstrate that the polymerase protein genes of the Edmonston strain contribute to its attenuated phenotype.
Published ahead of print on 17 September 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»